Sort
23,748 grants matching “melanoma”
Oncogenic Met Signaling in Urologic Malignancies
$522,479Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Tissue Resident memory T cell responses to cancer
$522,276Mary J Turk · Dartmouth College · R01 · FY2022 · CA
6-thio-2'-deoxyguanosine in GBM: Pre-clinical Evaluation of Mechanism of action, Efficacy and Biomarker identification
$522,189David M. Ashley · Duke University · U19 · FY2022 · CA
Targeting Systems Vulnerabilities in the Gαq/GNAQ Oncogenic Signaling Circuitry: New Precision Therapies for Uveal Melanoma
$522,110J. Silvio Gutkind · University Of California, San Diego · R01 · FY2025 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
$521,990Ashani T Weeraratna · Johns Hopkins University · R01 · FY2022 · CA
Precision Medicine For Pediatric Low-Grade Gliomas
$521,946Daphne A. Haas-Kogan · Dana-Farber Cancer Inst · R01 · FY2016 · NS
Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids
$521,890Chad A. Mirkin · Northwestern University · R01 · FY2022 · CA
Intratumoral Cytokine Immunotherapy Studies in Companion Canine Cancer Models
$521,821Karl D Wittrup · Massachusetts Institute Of Technology · R01 · FY2022 · CA
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$521,804Theresa A Guise · Indiana University Indianapolis · U01 · FY2014 · CA
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$521,786Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$521,765Philip D Greenberg · University Of Washington · R01 · FY2014 · CA
Stromal Regulation of Basal Cell Carcinoma Formation
$521,703Anthony E Oro · Stanford University · R01 · FY2025 · AR
Applying Genomic Dosimeters of UV Damage to Predicting Skin Cancer Risk
$521,690Douglas E Brash · Yale University · R01 · FY2023 · ES
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$521,604Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
$521,582Bin Zhang · Northwestern University At Chicago · R01 · FY2022 · CA
(PQ8) Patient- and tumor-specific biomarkers and mechanisms that predict irAEs resulting from checkpoint inhibition
$521,546Justin M Balko · Vanderbilt University Medical Center · R01 · FY2020 · CA
Project 1- Bioadhesive Sunscreens and Triplet-State Quenchers for Melanoma Prevention
$521,465Michael Girardi · Yale University · P50 · FY2020 · CA
Immunomodulating Ruthenium Metal Complexes for Melanoma PhotodynamicTherapy
$521,452Sherri McFarland · University Of Texas Arlington · R01 · FY2021 · CA
The KIT Signaling Pathway as a Therapeutic Target in Melanoma
$521,443Boris C Bastian · Wistar Institute · P01 · FY2015 · CA
Hemodynamic Noninvasive Skin Cancer Diagnostics
$521,409Mirianas Chachisvilis · Veriskin, Inc. · R44 · FY2016 · CA
Immunomodulating Ruthenium Metal Complexes for Melanoma Photodynamic Therapy
$521,279Sherri McFarland · University Of North Carolina Greensboro · R01 · FY2018 · CA
Development of an LXR agonist as first in class therapy for treatment of metastatic melanoma
$521,277Isabel Kurth · Rgenix, Inc. · R44 · FY2017 · CA
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
$521,056Richard J Price · University Of Virginia · R01 · FY2016 · CA
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems
$521,044Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Epidemiology of Cancer in a Cohort of Older Women
$520,999Aaron R Folsom · University Of Minnesota · R01 · FY2007 · CA